Jeff Yass’s Silexion Therapeutics Warrant SLXNW Stock Holding History

Jeff Yass’s Portfolio SLXNW Stock Details SLXNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.8K	Buy	+92,073	New	+$2.01K	﹤0.01%	13218
2025 Q4	–	Sell	-220,053	Closed	-$7.75K	–	13909
2025 Q3	$7.75K	Buy	220,053 +69,071	+46%	+$2.42K	﹤0.01%	12114
2025 Q2	$5.75K	Buy	150,982 +99,181	+191%	+$5.26K	﹤0.01%	12435
2025 Q1	$3.63K	Buy	+51,801	New	+$3.15K	﹤0.01%	12274
2024 Q4	–	Sell	-34,577	Closed	-$1.1K	–	13450
2024 Q3	$1.1K	Buy	+34,577	New	+$2K	﹤0.01%	11804

Other funds holding SLXNW

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return

Jeff Yass's SLXNW Position: Q2 2026 in Review

Jeff Yass opened a new position in Silexion Therapeutics Warrant (SLXNW) in Q2 2026: 92,073 shares worth $2.8K. The stake represents ﹤0.01% of the portfolio and ranks #13218 among its holdings. This is a return to the name: Jeff Yass previously reported a position in SLXNW as recently as Q3 2025.

Jeff Yass first reported a position in SLXNW in Q3 2024 and has held it in 5 quarters since. The position peaked at $7.75K in Q3 2025. 19 funds tracked by Wall St. Rank hold SLXNW as of Q2 2026.

Jeff Yass held 92,073 shares of Silexion Therapeutics Warrant worth $2.8K as of Q2 2026.
Silexion Therapeutics Warrant was a new Jeff Yass position in Q2 2026.
Silexion Therapeutics Warrant made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13218 holding.
Jeff Yass first reported a position in Silexion Therapeutics Warrant in Q3 2024 and has held it in 5 quarters since.
Jeff Yass's Silexion Therapeutics Warrant position peaked at $7.75K in Q3 2025.
19 funds tracked by Wall St. Rank held Silexion Therapeutics Warrant as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.